Published in Am J Kidney Dis on November 01, 2000
Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol (2009) 2.45
Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol (2012) 1.67
Age and comorbidities are effect modifiers of gender disparities in renal transplantation. J Am Soc Nephrol (2009) 1.64
Racial ethnic differences in rates and determinants of deceased donor kidney transplantation. J Am Soc Nephrol (2011) 1.48
Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol (2001) 1.42
Equity of access to renal transplant waiting list and renal transplantation in Scotland: cohort study. BMJ (2003) 1.38
Race and kidney disease: role of social and environmental factors. J Natl Med Assoc (2002) 1.18
Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales. Nephrol Dial Transplant (2009) 1.18
Association of race and insurance type with delayed assessment for kidney transplantation among patients initiating dialysis in the United States. Clin J Am Soc Nephrol (2012) 1.18
Variation between centres in access to renal transplantation in UK: longitudinal cohort study. BMJ (2010) 1.10
A decade of experience with renal transplantation in African-Americans. Ann Surg (2002) 1.06
Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant (2010) 1.01
Health-related and psychosocial concerns about transplantation among patients initiating dialysis. Clin J Am Soc Nephrol (2014) 0.94
Trends in the inactive kidney transplant waitlist and implications for candidate survival. Am J Transplant (2013) 0.93
Racial and ethnic disparities in renal transplantation. J Natl Med Assoc (2005) 0.90
Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis. BMJ Open (2016) 0.85
Differential association of body mass index with access to kidney transplantation in men and women. Clin J Am Soc Nephrol (2014) 0.82
The role of minority geographic distribution in waiting time for deceased donor kidney transplantation. Am J Transplant (2014) 0.80
Simulating the new kidney allocation policy in the United States: modest gains and many unknowns. J Am Soc Nephrol (2014) 0.80
Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant (2015) 0.80
Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index. Clin Transplant (2012) 0.78
Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease. PLoS One (2016) 0.77
Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol (2016) 0.76
Reducing disparities in assessment for kidney transplantation. Clin J Am Soc Nephrol (2012) 0.76
Are there good reasons for inequalities in access to renal transplantation in children? Nephrol Dial Transplant (2014) 0.75
Proximity Does Not Equal Access: Racial Disparities in Access to High Quality Dialysis Facilities. J Racial Ethn Health Disparities (2014) 0.75
Understanding Racial Differences in Deceased-Donor Kidney Transplantation: Geography, Poverty, Language, and Health Insurance Coverage. Dial Transplant (2011) 0.75
Registration on the renal transplantation waiting list and mortality on dialysis: an analysis of the French REIN registry using a multi-state model. J Epidemiol (2014) 0.75
Factors affecting willingness to receive a kidney transplant among minority patients at an urban safety-net hospital: a cross-sectional survey. BMC Nephrol (2015) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
A compendium of gene expression in normal human tissues. Physiol Genomics (2001) 5.66
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Transmission of hepatitis C virus by organ transplantation. N Engl J Med (1991) 5.17
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (1990) 4.40
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med (1992) 2.78
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res (1999) 1.78
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation (1997) 1.71
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation. Am J Transplant (2010) 1.55
Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol (2000) 1.45
Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis (1992) 1.45
Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders. Q J Med (1989) 1.43
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Hemodialysis vascular access morbidity in the United States. Kidney Int (1993) 1.41
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol (1994) 1.40
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int (1992) 1.38
Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant (2008) 1.38
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
A novel united network for organ sharing region kidney allocation plan improves transplant access for minority candidates. Transplantation (1999) 1.37
New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci. Nature (1992) 1.36
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
Association of gender and access to cadaveric renal transplantation. Am J Kidney Dis (1997) 1.33
Containing Medicaid costs in an era of growing physician supply. Health Care Financ Rev (1985) 1.33
Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int (1973) 1.32
Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis (1997) 1.29
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int (1996) 1.27
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26
Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med (1984) 1.25
Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int (1999) 1.25